BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15647230)

  • 1. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
    Zuvekas SH
    Health Aff (Millwood); 2005; 24(1):195-205. PubMed ID: 15647230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage for mental health treatment: do the gaps still persist?
    Zuvekas SH; Meyerhoefer CD
    J Ment Health Policy Econ; 2006 Sep; 9(3):155-63. PubMed ID: 17031020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and cost of mental health, substance abuse, and medical services among at-risk drinkers.
    Nietert PJ; French MT; Kirchner JE; Booth BM
    Med Care Res Rev; 2007 Aug; 64(4):431-48. PubMed ID: 17684111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in psychotropic medication costs for children and adolescents, 1997-2000.
    Martin A; Leslie D
    Arch Pediatr Adolesc Med; 2003 Oct; 157(10):997-1004. PubMed ID: 14557161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity on health service utilization and costs in childhood.
    Trasande L; Chatterjee S
    Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the slowdown in growth of spending for psychiatric drugs, 1986-2008.
    Mark TL; Kassed C; Levit K; Vandivort-Warren R
    Psychiatr Serv; 2012 Jan; 63(1):13-8. PubMed ID: 22227754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
    Hennessy KD; Green-Hennessy S; Buck JA; Miller K
    J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
    [No Abstract]   [Full Text] [Related]  

  • 11. U.S. spending for mental health and substance abuse treatment, 1991-2001.
    Mark TL; Coffey RM; Vandivort-Warren R; Harwood HJ; King EC;
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-133-W5-142. PubMed ID: 15797947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking inside the nation's medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001.
    Moeller JF; Miller GE; Banthin JS
    Health Aff (Millwood); 2004; 23(5):217-25. PubMed ID: 15371388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in mental health cost growth: an expanded role for management?
    Frank RG; Goldman HH; McGuire TG
    Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001-2009.
    Mark TL; Vandivort-Warren R
    Drug Alcohol Depend; 2012 Oct; 125(3):203-7. PubMed ID: 22436972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid policy changes in mental health care and their effect on mental health outcomes.
    Cuellar AE; Markowitz S
    Health Econ Policy Law; 2007 Jan; 2(Pt 1):23-49. PubMed ID: 18634670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey.
    Devine JW; Farley JF; Hadsall RS
    Headache; 2005 Oct; 45(9):1171-80. PubMed ID: 16178947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends in the use of outpatient psychotherapy.
    Olfson M; Marcus SC; Druss B; Pincus HA
    Am J Psychiatry; 2002 Nov; 159(11):1914-20. PubMed ID: 12411228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.